Other languages Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
42.82 ^USD	+0.33%		+0.30%	+2.49%

May. 23	Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	MT
May. 22	Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	May. 23
Taro Shareholders Approve Merger with Sun Pharma	May. 23
Taro Shareholders Approve Merger with Sun Pharma	May. 23
Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K	May. 23
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call	May. 22
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call	May. 22
Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K	May. 21
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise	May. 20
Taro: Fiscal Q4 Earnings Snapshot	May. 20
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M	May. 20
Taro Provides Results for Year Ended March 31, 2024	May. 20
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024	May. 20
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 20
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.	May. 20
Taro to Release Full Year Results on May 20, 2024	May. 15
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger	May. 09
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger	May. 08
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS	Apr. 23
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO	Apr. 22
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.	Apr. 15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Other languages

Filters